$HALO

$110.00▲ +0.3% YTD

6 SEC 13D/G filings tracked · Last updated Oct 7, 2026

Filing History

HALO ▲ +0.3% - Halozyme Therapeutics, Inc.

CP $110.00▲ +0.3%Oct 7, 2026 · ThinkSabio Blog

$HALO HALO - Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets…

News

HALO ▲ +1.6% - Halozyme Therapeutics, Inc.

CP $110.00▲ +1.6%Oct 6, 2026 · ThinkSabio Blog

$HALO - Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations…

News

HALO ▼ -1.1% - Halozyme Therapeutics, Inc.

CP $110.38▲ -1.1%Sep 30, 2026 · ThinkSabio Blog

$HALO HALO - Halozyme Announces Appointment of Jim Daly to its Board of Directors…

News

HALO ▲ +1.2% - Halozyme Therapeutics, Inc.

CP $109.68▲ +1.2%Sep 18, 2026 · ThinkSabio Blog

$HALO HALO - Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033…

News

HALO ▲ +0.8% - Halozyme Therapeutics, Inc.

CP $107.11▲ +0.8%Sep 16, 2026 · ThinkSabio Blog

$HALO - Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033…

News

HALO ▼ -0.9% - Halozyme Therapeutics, Inc.

CP $106.75▲ -0.9%Sep 2, 2026 · ThinkSabio Blog

$HALO HALO - Halozyme to Participate at Upcoming Investor Conferences…